BRCA2 and non-Hodgkin lymphoma: In conclusion, our meta-analysis determined that the BRCA2 rs144848 polymorphism was associated with non-Hodgkin lymphoma, and indicated that the rs144848 H allele of the BRCA2 gene may be a low-penetrate risk factor enhancing carcinogenesis in breast cancer.